US Patent 11607453 Mesothelin binding proteins
Patent 11607453 was granted and assigned to Harpoon Therapeutics on March, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Bryan D. Lemon0
Holger Wesche0
Richard J. Austin0
Robert B. Dubridge0
Edits on 22 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 11 Apr, 2023
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+309 characters)
US Patent 11607453 Mesothelin binding proteins
Article
Disclosed herein are MSLN binding proteins with improved binding affinities and improved ability to mediate T cell dependent killing of cancer cells expressing mesothelin. Pharmaceutical compositions comprising the binding proteins disclosed herein and methods of using such formulations are further provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116074530
Date of Patent
March 21, 2023
0Patent Application Number
167738430
Date Filed
January 27, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11607453 Mesothelin binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.